SCHEMBL6837676

SCHEMBL6837676

NCCn1c(-c2ccccc2)nc2c(C(F)(F)F)nc3ccccc3c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.42
TLR7 Q9NYK1 6/20 0.40
JAK2 O60674 2/20 0.40
JAK1 P23458 2/20 0.40
TYK2 P29597 2/20 0.40
JAK3 P52333 2/20 0.40
CASR P41180 1/20 0.39
ALDH1A1 P00352 5/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
LMNA P02545 1/20 0.38
RECQL P46063 1/20 0.38
RAB9A P51151 1/20 0.38
TLR8 Q9NR97 2/20 0.37
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.35
ENPP1 P22413 1/20 0.35
PDE6D O43924 1/20 0.35
ALDH2 P05091 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6840083 0.85 ALDH1A1 (0.43) TLR7CASRALDH1A1SMN1; SMN2TSHR
SCHEMBL6833754 0.84 TLR7 (0.34) EGFRTLR7TLR8
SCHEMBL6833826 0.83 AVPR1B (0.39) TLR7CASRALDH1A1TLR8GAA
SCHEMBL6838642 0.81 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2GAATSHRKMT2A
SCHEMBL6833799 0.80 TLR7 (0.46) TLR7CASRALDH1A1SMN1; SMN2LMNA
SCHEMBL6838095 0.80 MTNR1A (0.50) TLR7ALDH1A1LMNATP53TSHR
SCHEMBL6833713 0.80 NPY1R (0.39) TLR7CASRPDE6D
SCHEMBL6833915 0.80 MTNR1A (0.39) EGFRTLR7CASRALDH1A1SMN1; SMN2
SCHEMBL6838696 0.79 NPY1R (0.40) TLR7PDE6D
SCHEMBL6838401 0.79 MTNR1A (0.40) EGFRTLR7CASRALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 EGFR 1771/4885TLR7 964/4885JAK2 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.